发明名称 Cycloalkyl alkanoic acids as integrin receptor antagonists
摘要 The present invention relates to a class of compounds represented by the Formula I Wherein A<SUP>1 </SUP>is a pyridinyl of the formula optionally substituted by one or more R<SUP>k </SUP>selected from the group consisting of hydroxy, alkyl, alkoxy, alkoxyalkyl, thioalkyl, haloalkyl, cyano, amino alkylamino, halogen, acylamino, sulfonamide and -COR; and R is hydroxy, alkoxy, alkyl or amino; and pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the alpha<SUB>v</SUB>beta<SUB>3 </SUB>and/or alpha<SUB>v</SUB>beta<SUB>5 </SUB>integrin.
申请公布号 AU6982101(A) 申请公布日期 2001.12.24
申请号 AU20010069821 申请日期 2001.06.15
申请人 PHARMACIA CORPORATION;ISH KUMAR KHANNA;MICHAEL CLARE;ALAN F. GASIECKI;THOMAS ROGERS;BARBARA CHEN;MARK RUSSEL;LU HWANG-FUN 发明人 ISH KUMAR KHANNA;MICHAEL CLARE;ALAN F. GASIECKI;THOMAS ROGERS;BARBARA CHEN;MARK RUSSEL;LU HWANG-FUN
分类号 A61K31/4168;A61K31/4375;A61K31/44;A61K31/4402;A61K31/443;A61K31/4439;A61K31/444;A61K31/5383;A61P3/14;A61P9/00;A61P9/10;A61P19/02;A61P19/10;A61P21/00;A61P27/02;A61P35/00;A61P35/04;C07D213/74;C07D231/38;C07D233/88;C07D405/12;C07D413/12;C07D417/12;C07D471/04;C07D498/04 主分类号 A61K31/4168
代理机构 代理人
主权项
地址